Target intelligence / Profile preview

Microbial cell membranes and surface proteins

Molecular classification
Transporter, Receptor, Lipid, Protein, Other
01

Overview

Microbial cell membranes and surface proteins are fundamental structures that maintain the viability and virulence of pathogens. The bacterial cytoplasmic membrane and the outer membrane of Gram-negative bacteria serve as critical barriers and sites for energy transduction and nutrient transport (Silhavy et al., 2010, Cold Spring Harbor Perspectives in Biology). These membranes contain unique components not found in human cells, such as lipopolysaccharides (LPS) in bacteria and ergosterol in fungi, which provide a basis for selective toxicity (Li et al., 2006, Clinical Infectious Diseases). Drugs like polymyxins and daptomycin target these membranes to cause rapid depolarization and cell death, while surface proteins like adhesins are targeted to prevent host tissue colonization (Foster et al., 2014, Nature Reviews Microbiology). Despite their clinical utility, targeting these structures can be associated with significant side effects, such as nephrotoxicity, and is increasingly complicated by the emergence of sophisticated resistance mechanisms (Brogden, 2005, Nature Reviews Microbiology).

Other names
Microbial cell envelopeBacterial cell membraneFungal cell membraneMicrobial surface componentsCytoplasmic membraneMSCRAMMsBacterial cell envelope
02

Mechanism of action

Antimicrobials targeting these structures typically act through physical disruption of the lipid bilayer (e.g., polymyxins binding to LPS), pore formation leading to cytoplasmic leakage (e.g., daptomycin or amphotericin B), or by blocking surface proteins involved in adhesion and host cell entry (Papo & Shai, 2005, Biochemistry; Epand & Vogel, 1999, Biochimica et Biophysica Acta).

03

Biological functions

Signal transductionCell deathImmune responseBarrier functionOther
04

Disease associations

InfectionInflammationSepsisOther
05

Safety considerations

NephrotoxicityNeurotoxicityMyopathyHemolysisAntimicrobial resistance
06

Interacting drugs

Colistin

8 more in the full profile.

07

Biomarkers

ProcalcitoninC-reactive protein1,3-beta-D-glucanGalactomannan

Beyond the preview

Go deeper on Microbial cell membranes and surface proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial cell membranes and surface proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call